114 related articles for article (PubMed ID: 2932217)
21. In vitro activity of menogaril and N-demethylmenogaril in a human tumor cloning assay.
Dodion P; Sanders C; Rombaut W; Rozencweig M; Kitt MM; Kenis Y; Klastersky J
Eur J Cancer Clin Oncol; 1986 Mar; 22(3):245-9. PubMed ID: 2940092
[TBL] [Abstract][Full Text] [Related]
22. Effect of 7-con-O-methylnogarol on DNA synthesis, survival, and cell cycle progression of Chinese hamster ovary cells.
Adams EG; Crampton SL; Bhuyan BK
Cancer Res; 1981 Dec; 41(12 Pt 1):4981-7. PubMed ID: 6458356
[TBL] [Abstract][Full Text] [Related]
23. Phase I clinical and pharmacokinetic trial of oral menogaril administered on three consecutive days.
Dodion P; de Valeriola D; Crespeigne N; Peeters B; Wery F; van Berchem C; Piccart M; Tueni E; Joggi J; Kenis Y
Eur J Cancer Clin Oncol; 1988 Jun; 24(6):1019-26. PubMed ID: 2970391
[TBL] [Abstract][Full Text] [Related]
24. Failure of aclacinomycin and 7-con-O-methylnogarol (7-OMEN) to decrease cardiac guanylate cyclase activity.
Levey BA; Ruiz E; Rogerson B; Lehotay DC; Levey GS
Cancer Treat Rep; 1980; 64(10-11):1127-8. PubMed ID: 6109566
[No Abstract] [Full Text] [Related]
25. Disposition and metabolism of the new hypocholesterolemic compound S-8921 in rats and dogs.
Yamaguchi T; Nakajima Y; Mizobuchi M; Inazawa K; Kanazu T; Kadono K; Ohkawa T; Iwatani K
Arzneimittelforschung; 1998 Oct; 48(10):995-1006. PubMed ID: 9825117
[TBL] [Abstract][Full Text] [Related]
26. Studies on the metabolism of the novel antitumor agent [N-methyl-11C]N-[2-(dimethylamino)ethyl]acridine-4-carboxamide in rats and humans prior to phase I clinical trials.
Osman S; Luthra SK; Brady F; Hume SP; Brown G; Harte RJ; Matthews JC; Denny WA; Baguley BC; Jones T; Price PM
Cancer Res; 1997 Jun; 57(11):2172-80. PubMed ID: 9187117
[TBL] [Abstract][Full Text] [Related]
27. A phase I study of menogaril in patients with advanced cancer.
Brown TD; Donehower RC; Grochow LB; Rice AP; Ettinger DS
J Clin Oncol; 1987 Jan; 5(1):92-9. PubMed ID: 2949065
[TBL] [Abstract][Full Text] [Related]
28. Cell kill kinetics of several nogalamycin analogs and adriamycin for Chinese hamster ovary, L1210 leukemia, and B16 melanoma cells in culture.
Bhuyan BK; Blowers CL; Crampton SL; Shugars KD
Cancer Res; 1981 Jan; 41(1):18-24. PubMed ID: 7448758
[TBL] [Abstract][Full Text] [Related]
29. Disposition of amphotericin B in the isolated perfused rat liver.
Hong Y; Ramzan I; McLachlan AJ
J Pharm Pharmacol; 2004 Jan; 56(1):35-41. PubMed ID: 14979999
[TBL] [Abstract][Full Text] [Related]
30. Pharmacokinetics of 7-con-O-methylnogarol in patients with solid tumors.
Zanette ML; Tirelli U; Sorio R; Zadro D; Figoli F; Monfardini S; D'Incalci M
Cancer Chemother Pharmacol; 1987; 20(1):67-70. PubMed ID: 2957106
[TBL] [Abstract][Full Text] [Related]
31. Kinetics and disposition of hexarelin, a peptidic growth hormone secretagogue, in rats.
Roumi M; Marleau S; du Souich P; Maggi T; Deghenghi R; Ong H
Drug Metab Dispos; 2000 Jan; 28(1):44-50. PubMed ID: 10611139
[TBL] [Abstract][Full Text] [Related]
32. Biliary elimination and hepatic disposition of a new fluoroquinolone, temafloxacin: experimental evaluation.
Brogard JM; Koechlin C; Westphal JF; Blicklé JF; Dorner M; Jehl F
Drugs Exp Clin Res; 1990; 16(8):407-16. PubMed ID: 2097145
[TBL] [Abstract][Full Text] [Related]
33. Human autopsy-tissue distribution of menogaril and its metabolites.
Stewart DJ; Grewaal D; Green RM; Goel R; Mikhael N; Montpetit VA; Redmond D; Earhart R
Cancer Chemother Pharmacol; 1993; 32(5):373-8. PubMed ID: 8339388
[TBL] [Abstract][Full Text] [Related]
34. Disposition of the novel anticancer agent vinorelbine ditartrate following intravenous administration in mice, rats and dogs.
Kobayashi S; Sakai T; Dalrymple PD; Wood SG; Chasseaud LF
Arzneimittelforschung; 1993 Dec; 43(12):1367-77. PubMed ID: 8141830
[TBL] [Abstract][Full Text] [Related]
35. [Antitumor spectrum of TUT-7 on rat ascitic hepatoma].
Satoh H; Taguchi H; Yahagi S
Gan To Kagaku Ryoho; 1990 Feb; 17(2):287-91. PubMed ID: 2137321
[TBL] [Abstract][Full Text] [Related]
36. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
[TBL] [Abstract][Full Text] [Related]
37. Pharmacokinetic and metabolism studies of two novel 1-deaza-7,8-dihydropteridines in mice.
Noker PE; Hill DL; Kalin JR; Temple CG; Montgomery JA
Drug Metab Dispos; 1985; 13(6):677-81. PubMed ID: 2867870
[TBL] [Abstract][Full Text] [Related]
38. Metabolism, distribution, seminal excretion and pharmacokinetics of caffeine in the rabbit.
Beach CA; Mays DC; Sterman BM; Gerber N
J Pharmacol Exp Ther; 1985 Apr; 233(1):18-23. PubMed ID: 3981454
[TBL] [Abstract][Full Text] [Related]
39. Phase I study of intravenous menogaril administered intermittently.
Dodion P; Sessa C; Joss R; Crespeigne N; Willems Y; Kitt M; Abrams J; Finet C; Brewer JE; Adams WJ
J Clin Oncol; 1986 May; 4(5):767-74. PubMed ID: 2939203
[TBL] [Abstract][Full Text] [Related]
40. Pharmacokinetic studies in mice of two new thioxanthenones (183577 and 232759) that showed preferential solid tumor activity.
Foster BJ; Wiegand RA; Pugh S; LoRusso PM; Rake J; Corbett TH
Clin Cancer Res; 1997 Nov; 3(11):2047-53. PubMed ID: 9815596
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]